| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2015 | Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma | JIA-HUEI TSAI ; Lin Y.-L.; Cheng Y.-C.; CHIEN-CHUAN CHEN ; LIANG-IN LIN ; LI-HUI TSENG ; Cheng M.-L.; JAU-YU LIAU ; YUNG-MING JENG | Modern Pathology | 32 | 30 | |
| 2006 | Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1] | Chen C.-Y.; LIANG-IN LIN ; JIH-LUH TANG ; Tsay W.; HSIU-HAO CHANG ; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; MING YAO ; BOR-SHENG KO ; YAO-CHANG CHEN ; Lin K.-H.; Lin D.-T.; HWEI-FANG TIEN | Leukemia | 35 | 36 | |
| 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen C.-Y.; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; Tsay W.; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 50 | 47 | |
| 1994 | Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients | Hsu H.C.; Peng S.Y.; Lai P.L.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; LIANG-IN LIN ; Slagle B.L.; Butel J.S. | Cancer | 57 | | |
| 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen C.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; Tsay W.; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 265 | 246 | |
| 1994 | The amplification refractory mutation system (ARMS): a rapid and direct prenatal diagnostic technique for β-thalassaemia in Singapore | Tan J.A.M.A.; Tay J.S.H.; LIANG-IN LIN ; Kham S.K.Y.; Chia J.N.; Chin T.M.; Adb. Aziz N.Bt.; Wong H.B. | Prenatal Diagnosis | 40 | 31 | |
| 1992 | Analysis of hemoglobin gamma chain in patients with Cooley's anemia in Taiwan. | LIANG-IN LIN ; Lin K.S.; Lin D.T. | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
| 2008 | Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning | Huang C.-P.; WOEI-HORNG FANG ; LIANG-IN LIN ; Chiou R.Y.; Kan L.-S.; Chi N.-H.; Chen Y.-R.; Lin T.-Y.; Lin S.-B. | Toxicology and Applied Pharmacology | 15 | 12 | |
| 2016 | Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission | Wang Y.-M.; Lu J.-W.; Lin C.-C.; Chin Y.-F.; Wu T.-Y.; LIANG-IN LIN ; Lai Z.-Z.; Kuo S.-C.; Ho Y.-J. | Antiviral Research | 71 | 62 | |
| 2018 | Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay | KANG-YI SU ; Lai H.-M.; Goodman S.D.; Hu W.-Y.; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; WOEI-HORNG FANG | DNA Repair | 5 | 4 | |
| 2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | KUO-HSING CHEN ; LIANG-IN LIN ; CHANG-TSU YUAN ; LI-HUI TSENG ; Chao, Yu-Liang; YI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | British journal of cancer | 0 | 0 | |
| 2012 | Autophagy: Resetting glutamine-dependent metabolism and oxygen consumption | Lin T.-C.; Chen Y.-R.; Kensicki E.; Li A.Y.-J.; Kong M.; Li Y.; Mohney R.P.; Shen H.-M.; Stiles B.; Mizushima N.; LIANG-IN LIN ; Ann D.K. | Autophagy | 50 | 47 | |
| 2016 | BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer | KUO-HSING CHEN ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | Medical Oncology | 17 | 16 | |
| 2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen C.-Y; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 24 | 25 | |
| 2022 | Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation | Fu, Yu-Hsuan; DA-LIANG OU ; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan; HWEI-FANG TIEN ; Shen, Che-Kun James; Shen, Che-Kun James; Chien, Hsiung-Fei; LIANG-IN LIN | Cancer Gene Therapy | 1 | 1 | |
| 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 38 | 37 | |
| 1990 | Cell type-specific protein-DNA interactions in the human ζ-globin upstream promoter region: Displacement of Sp1 by the erythroid cell-specific factor NF-E1 | Yu C.-Y.; Chen J.; LIANG-IN LIN ; Tam M.; Shen C.-K.J. | Molecular and Cellular Biology | 27 | 42 | |
| 2015 | Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations | YI-HSIN LIANG ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LI-HUI TSENG ; LIANG-IN LIN ; YIH-LEONG CHANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 4 | 4 | |
| 2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; Chen C.-Y.; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; HWEI-FANG TIEN | Leukemia | 52 | 51 | |
| 2005 | Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells | LIANG-IN LIN ; Chen C.-Y.; Lin D.-T.; Tsay W.; JIH-LUH TANG ; Yeh Y.-C.; Shen H.-L.; Su F.-H.; MING YAO ; Huang S.-Y.; HWEI-FANG TIEN | Clinical Cancer Research | 172 | 172 | |
